Effects of RT234 on Exercise Parameters Accessed by CPET in Subjects With PAH
Condition: Pulmonary Arterial Hypertension Intervention: Combination Product: Drug: RT234 - vardenafil inhalation powder; Device: Axially Oscillating Sphere dry powder inhaler (AOS DPI) Sponsors: Respira Therapeutics, Inc.; Argint International; Precision For Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials